Home
>
National Drug Code (NDC)
>
Adoxa
Adoxa - 10337-815-06 - (doxycycline)
Drug Information of Adoxa
| Product NDC: | 10337-815 |
| Proprietary Name: | Adoxa |
| Non Proprietary Name: | doxycycline |
| Active Ingredient(s): | 150 mg/1 & nbsp; doxycycline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Adoxa
| Product NDC: | 10337-815 |
| Labeler Name: | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065055 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110601 |
Package Information of Adoxa
| Package NDC: | 10337-815-06 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (10337-815-06) |
NDC Information of Adoxa
| NDC Code | 10337-815-06 |
| Proprietary Name | Adoxa |
| Package Description | 60 CAPSULE in 1 BOTTLE (10337-815-06) |
| Product NDC | 10337-815 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | doxycycline |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110601 |
| Marketing Category Name | ANDA |
| Labeler Name | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
| Substance Name | DOXYCYCLINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
